Published in Endocrinology on December 01, 1993
Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci U S A (2001) 3.23
Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats. Biol Psychiatry (2006) 2.70
Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci U S A (1995) 2.70
Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci U S A (1994) 2.14
Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets. CNS Neurol Disord Drug Targets (2006) 1.97
Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc Natl Acad Sci U S A (1995) 1.86
Immunocytochemical distribution of corticotropin-releasing hormone receptor type-1 (CRF(1))-like immunoreactivity in the mouse brain: light microscopy analysis using an antibody directed against the C-terminus. J Comp Neurol (2000) 1.70
Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs. Front Neuroendocrinol (2006) 1.60
Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome. Gut (2004) 1.58
Differential regulation of the expression of corticotropin-releasing factor receptor type 2 (CRF2) in hypothalamus and amygdala of the immature rat by sensory input and food intake. J Neurosci (1999) 1.51
Local CRH signaling promotes synaptogenesis and circuit integration of adult-born neurons. Dev Cell (2014) 1.47
Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor. Proc Natl Acad Sci U S A (1995) 1.45
Developmental profile of messenger RNA for the corticotropin-releasing hormone receptor in the rat limbic system. Brain Res Dev Brain Res (1996) 1.44
Role of corticotropin releasing factor in anxiety disorders: a translational research perspective. Horm Behav (2006) 1.43
MPZP: a novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonist. Pharmacol Biochem Behav (2007) 1.39
The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist. Brain Res (1997) 1.28
A CRF(2) agonist administered into the central nucleus of the amygdala decreases ethanol self-administration in ethanol-dependent rats. Brain Res (2007) 1.28
Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30. Proc Natl Acad Sci U S A (1998) 1.23
Corticotropin-releasing factor in the basolateral amygdala enhances memory consolidation via an interaction with the beta-adrenoceptor-cAMP pathway: dependence on glucocorticoid receptor activation. J Neurosci (2008) 1.20
Tobacco addiction and the dysregulation of brain stress systems. Neurosci Biobehav Rev (2012) 1.09
The central corticotropin releasing factor system during development and adulthood. Eur J Pharmacol (2008) 1.08
Corticotropin-releasing factor binding protein within the ventral tegmental area is expressed in a subset of dopaminergic neurons. J Comp Neurol (2008) 1.08
Immediate and prolonged effects of alcohol exposure on the activity of the hypothalamic-pituitary-adrenal axis in adult and adolescent rats. Brain Behav Immun (2011) 0.97
The developmental profile of the corticotropin releasing factor receptor (CRF2) in rat brain predicts distinct age-specific functions. Brain Res Dev Brain Res (1998) 0.95
Corticotropin releasing factor receptor type II (CRF2) messenger ribonucleic acid levels in the hypothalamic ventromedial nucleus of the infant rat are reduced by maternal deprivation. Endocrinology (1997) 0.95
Functional and protein chemical characterization of the N-terminal domain of the rat corticotropin-releasing factor receptor 1. Protein Sci (2001) 0.91
Sex-biased stress signaling: the corticotropin-releasing factor receptor as a model. Mol Pharmacol (2012) 0.91
Development neurobiology of the stress response: multilevel regulation of corticotropin-releasing hormone function. Ann N Y Acad Sci (1997) 0.89
Synthesis and characterization of a photoactivatable analog of corticotropin-releasing factor for specific receptor labeling. Proc Natl Acad Sci U S A (1996) 0.88
Corticotropin-releasing factor-related peptides, serotonergic systems, and emotional behavior. Front Neurosci (2013) 0.88
Central corticotropin releasing factor and social stress. Front Neurosci (2013) 0.88
cAMP- and Ca²(+) /calmodulin-dependent protein kinases mediate inotropic, lusitropic and arrhythmogenic effects of urocortin 2 in mouse ventricular myocytes. Br J Pharmacol (2011) 0.86
Mapping of the ligand-selective domain of the Xenopus laevis corticotropin-releasing factor receptor 1: implications for the ligand-binding site. Proc Natl Acad Sci U S A (1998) 0.85
Alcohol, stress hormones, and the prefrontal cortex: a proposed pathway to the dark side of addiction. Neuroscience (2014) 0.85
Central CRF system perturbation in an Alzheimer's disease knockin mouse model. Neurobiol Aging (2012) 0.85
Local corticotropin releasing hormone (CRH) signals to its receptor CRHR1 during postnatal development of the mouse olfactory bulb. Brain Struct Funct (2014) 0.84
Corticotropin-releasing factor receptor subtype 2 in human colonic mucosa: down-regulation in ulcerative colitis. World J Gastroenterol (2013) 0.83
Plasma leptin and ghrelin in the neonatal rat: interaction of dexamethasone and hypoxia. J Endocrinol (2005) 0.83
Modulation of firing and synaptic transmission of serotonergic neurons by intrinsic G protein-coupled receptors and ion channels. Front Integr Neurosci (2013) 0.82
Topographical distribution of corticotropin-releasing factor type 2 receptor-like immunoreactivity in the rat dorsal raphe nucleus: co-localization with tryptophan hydroxylase. Neuroscience (2011) 0.82
Corticotropin releasing factor-induced CREB activation in striatal neurons occurs via a novel Gβγ signaling pathway. PLoS One (2011) 0.81
Modulation of corticotropin releasing factor (CRF) signaling through receptor splicing in mouse pituitary cell line AtT-20--emerging role of soluble isoforms. J Physiol Pharmacol (2009) 0.81
Corticotropin-releasing factor receptor type 1 and type 2 interaction in irritable bowel syndrome. J Gastroenterol (2015) 0.81
Divergent effects of corticotropin releasing hormone on endothelial cell nitric oxide synthase are associated with different expression of CRH type 1 and 2 receptors. Br J Pharmacol (2001) 0.80
Minireview: CRF and Wylie Vale: a story of 41 amino acids and a Texan with grit. Endocrinology (2012) 0.80
Nicotine stimulates secretion of corticosterone via both CRH and AVP receptors. J Neurochem (2012) 0.79
Corticotropin-releasing factor and urocortin I activate CREB through functionally selective Gβγ signaling in hippocampal pyramidal neurons. Eur J Neurosci (2011) 0.79
Urocortin 1 inhibits rat leydig cell function. Endocrinology (2008) 0.78
Mitragynine attenuates withdrawal syndrome in morphine-withdrawn zebrafish. PLoS One (2011) 0.78
Effects of peripherally administered urocortin 3 on feeding behavior and gastric emptying in mice. Exp Ther Med (2011) 0.76
Behavior and brain gene expression changes in mice exposed to preimplantation and prenatal stress. Reprod Sci (2014) 0.76
Corticotropin releasing factor excites neurons of posterior hypothalamic nucleus to produce tachycardia in rats. Sci Rep (2016) 0.75
Neuropeptide systems and new treatments for nicotine addiction. Psychopharmacology (Berl) (2016) 0.75
Short- and long-term effects of stress during adolescence on emotionality and HPA function of animals exposed to alcohol prenatally. Psychoneuroendocrinology (2016) 0.75
Regulation of corticotropin releasing hormone receptor type 1 messenger RNA level in Y-79 retinoblastoma cells: potential implications for human stress response and immune/inflammatory reaction. Mediators Inflamm (1996) 0.75
UMLS concept indexing for production databases: a feasibility study. J Am Med Inform Assoc (2001) 9.02
Organization of heterogeneous scientific data using the EAV/CR representation. J Am Med Inform Assoc (1999) 6.97
Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study. Lancet (2001) 6.67
A cluster of phosphorylation sites on the cyclic AMP-regulated nuclear factor CREB predicted by its sequence. Nature (1989) 5.89
Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature (1983) 5.20
Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology (1983) 4.67
Water diffusion changes in Wallerian degeneration and their dependence on white matter architecture. Neuroimage (2001) 4.48
GEM: a proposal for a more comprehensive guideline document model using XML. J Am Med Inform Assoc (2000) 4.46
Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science (2013) 4.17
Cosmid vectors for rapid genomic walking, restriction mapping, and gene transfer. Proc Natl Acad Sci U S A (1987) 4.13
Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha. J Immunol (1999) 3.99
Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell (1991) 3.28
Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci U S A (2001) 3.23
Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron (1998) 3.08
Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet (2000) 3.04
Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide. Leukemia (2012) 3.04
Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci U S A (2001) 2.87
Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci U S A (1993) 2.70
Primary structure of major outer membrane protein II (ompA protein) of Escherichia coli K-12. Proc Natl Acad Sci U S A (1980) 2.64
Primary structure of major outer membrane protein I of Escherichia coli B/r. Proc Natl Acad Sci U S A (1979) 2.60
The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesth Analg (2000) 2.56
Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis (2013) 2.52
Lewy bodies and parkinsonism in families with parkin mutations. Ann Neurol (2001) 2.50
Physical mapping of complex genomes by cosmid multiplex analysis. Proc Natl Acad Sci U S A (1989) 2.47
Mirror movements in parkinsonism: evaluation of a new clinical sign. J Neurol Neurosurg Psychiatry (2005) 2.35
A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3. Neurology (2012) 2.34
Lower BMI cut-off value to define obesity in Hong Kong Chinese: an analysis based on body fat assessment by bioelectrical impedance. Br J Nutr (2001) 2.25
A peripheral blood diagnostic test for acute rejection in renal transplantation. Am J Transplant (2012) 2.25
Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs. non-allergics. J Immunol Methods (2001) 2.22
Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial. Diabetes Obes Metab (2009) 2.19
Subthalamic deep brain stimulation at individualized frequencies for Parkinson disease. Neurology (2012) 2.18
Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci U S A (1994) 2.14
Simultaneous bilateral laser in situ keratomileusis: safety and efficacy. Ophthalmology (1999) 2.13
The safety of acellular pertussis vaccine vs whole-cell pertussis vaccine. A postmarketing assessment. Arch Pediatr Adolesc Med (1996) 2.11
The impact of pre-hospital thrombolytic treatment on re-infarction rates: analysis of the Myocardial Infarction National Audit Project (MINAP). Heart (2007) 2.06
Complete amino acid sequence and glycosylation sites of glycoprotein gp71A of Friend murine leukemia virus. Proc Natl Acad Sci U S A (1982) 2.06
Corticotropin releasing factor receptors and their ligand family. Ann N Y Acad Sci (1999) 2.04
Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects. Br J Cancer (2002) 2.03
Theaflavins in black tea and catechins in green tea are equally effective antioxidants. J Nutr (2001) 2.02
DNA-dependent protein kinase stimulates an independently active, nonhomologous, end-joining apparatus. Cancer Res (2000) 1.97
Radioimmunological screening method for specific membrane proteins. Anal Biochem (1979) 1.96
Interactions between two different inhibitory systems in the human motor cortex. J Physiol (2001) 1.91
An apoptosis-inducing genotoxin differentiates heterozygotic carriers for Werner helicase mutations from wild-type and homozygous mutants. Hum Genet (1997) 1.88
Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc Natl Acad Sci U S A (1995) 1.86
A force-plate actometer for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor. J Neurosci Methods (2001) 1.86
TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214. Oncogene (2010) 1.81
Risk of chronic arthropathy among women after rubella vaccination. Vaccine Safety Datalink Team. JAMA (1997) 1.78
Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study. J Neurosci (1985) 1.77
MMR2 immunization at 4 to 5 years and 10 to 12 years of age: a comparison of adverse clinical events after immunization in the Vaccine Safety Datalink project. The Vaccine Safety Datalink Team. Pediatrics (1997) 1.77
Low serum cholesterol and mortality. Which is the cause and which is the effect? Circulation (1995) 1.73
Modulation of urocortin-induced hypophagia and weight loss by corticotropin-releasing factor receptor 1 deficiency in mice. Endocrinology (2000) 1.72
Complications of laparoscopic procedures after concentrated training in urological laparoscopy. J Urol (2001) 1.71
Stimulation of noradrenergic sympathetic outflow by calcitonin gene-related peptide. Nature (1983) 1.70
Computation-directed identification of OxyR DNA binding sites in Escherichia coli. J Bacteriol (2001) 1.68
Adeno-associated virus-mediated gene transfer to the brain: duration and modulation of expression. Hum Gene Ther (1999) 1.67
Dextromethorphan decreases the excitability of the human motor cortex. Neurology (1998) 1.66
Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J Neurosci (1994) 1.65
Cloning of a second type of activin receptor and functional characterization in Xenopus embryos. Science (1992) 1.64
Amino-substituted thalidomide analogs: potent inhibitors of TNF-alpha production. Bioorg Med Chem Lett (1999) 1.62
Effect of saxagliptin monotherapy in treatment-naïve patients with type 2 diabetes. Curr Med Res Opin (2009) 1.62
The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF. Proc Natl Acad Sci U S A (1992) 1.60
A clone-array pooled shotgun strategy for sequencing large genomes. Genome Res (2001) 1.60
Involvement of the human pedunculopontine nucleus region in voluntary movements. Neurology (2010) 1.60
Involvement of the human subthalamic nucleus in movement preparation. Neurology (2003) 1.59
Transcranial magnetic stimulation for the treatment of seizures: a controlled study. Neurology (2002) 1.59
Intracellular Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in buccal epithelial cells collected from human subjects. Infect Immun (2001) 1.58
Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors. J Comp Neurol (1999) 1.57
Somatotroph hypoplasia and dwarfism in transgenic mice expressing a non-phosphorylatable CREB mutant. Nature (1991) 1.55
The pharmacology of bimatoprost (Lumigan). Surv Ophthalmol (2001) 1.54
Nucleotide sequence of the gene for the peptidoglycan-associated lipoprotein of Escherichia coli K12. Eur J Biochem (1987) 1.53
Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension (1995) 1.53
Antibacterial agents that inhibit two-component signal transduction systems. Proc Natl Acad Sci U S A (1998) 1.53
The primary structure of protein L16 located at the peptidyltransferase center of Escherichia coli ribosomes. FEBS Lett (1976) 1.53
Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor-binding proteins. Nature (1991) 1.51
Inflammatory pseudotumor of the liver. Report of the fine needle aspiration cytologic findings in a case initially misdiagnosed as malignant. Acta Cytol (1989) 1.51
Root gravitropism: an experimental tool to investigate basic cellular and molecular processes underlying mechanosensing and signal transmission in plants. Annu Rev Plant Biol (2002) 1.51
Induction of microsatellite instability by oxidative DNA damage. Proc Natl Acad Sci U S A (1998) 1.51
- cross-linking sites in human and bovine fibrin. Biochemistry (1971) 1.50
A single nuclease active site of the Escherichia coli RecBCD enzyme catalyzes single-stranded DNA degradation in both directions. J Biol Chem (2000) 1.49
A tissue-specific enhancer confers Pit-1-dependent morphogen inducibility and autoregulation on the pit-1 gene. Genes Dev (1993) 1.48
A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly. J Lipid Res (2004) 1.48
Co-expression of corticotropin-releasing factor and vasopressin immunoreactivity in parvocellular neurosecretory neurons of the adrenalectomized rat. Proc Natl Acad Sci U S A (1984) 1.48
Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial. Int J Clin Pract (2009) 1.47
Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways. Oncogene (2009) 1.47
Gemcitabine and pemetrexed administered in rapid sequence as front-line chemotherapy for advanced non-small-cell lung cancer: a phase II clinical trial. Ann Oncol (2009) 1.45
Physiologic testosterone levels in normal men suppress high-density lipoprotein cholesterol levels. Ann Intern Med (1992) 1.43
Guidelines for Good Epidemiology Practices for drug, device, and vaccine research in the United States. Pharmacoepidemiol Drug Saf (1996) 1.43
Pharmacological characterization of a novel antiglaucoma agent, Bimatoprost (AGN 192024). J Pharmacol Exp Ther (2003) 1.42
Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury. Circulation (2001) 1.41
The effects of drinks made from simple sugars on blood pressure in healthy older people. Br J Nutr (2005) 1.41
Inhibitory influence of the ipsilateral motor cortex on responses to stimulation of the human cortex and pyramidal tract. J Physiol (1998) 1.40
Children and international travel: immunizations. Pediatr Infect Dis J (1995) 1.39
Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Tannerella forsythensis are components of a polymicrobial intracellular flora within human buccal cells. J Dent Res (2005) 1.39
Corticotropin-releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide. Psychopharmacology (Berl) (1986) 1.38
The sequence determination of a protein in a micro scale: the sequence analysis of ribosomal protein L34 of Escherichia coli. Hoppe Seylers Z Physiol Chem (1976) 1.37
ARG1 (altered response to gravity) encodes a DnaJ-like protein that potentially interacts with the cytoskeleton. Proc Natl Acad Sci U S A (1999) 1.36
Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist. J Clin Endocrinol Metab (1983) 1.36
The reporting sensitivities of two passive surveillance systems for vaccine adverse events. Am J Public Health (1995) 1.36